Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection

Infection and Immunity

Volumn 61, Issue 8, 1993, Pages 3351-3359

  McMahon Pratt, D ^a   Rodriguez, D ^a   Rodriguez, J R ^a   Zhang, Y ^a   Manson, K ^a   Bergman, C ^a   Rivas, L ^a   Rodriguez, J F ^a   Lohman, K L ^a   Ruddle, N H ^a   Esteban, M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT VACCINE; VACCINIA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; LEISHMANIA; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMAL; FEMALE; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; VACCINATION; VACCINES, SYNTHETIC; VACCINIA VIRUS;

EID: 0027233931     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)